Evidence map›Paper›PMID 38874156›Full record

ArticleRenal failure2024

Usp9x contributes to the development of sepsis-induced acute kidney injury by promoting inflammation and apoptosis in renal tubular epithelial cells via activation of the TLR4/nf-κb pathway.

Shuhao Gong, Huawei Xiong, Yingchao Lei, Shipeng Huang, Yingdong Ouyang, Chunshui Cao, Ying Wang

Abstract read
In one paragraph

Article in Renal failure, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. The roles of the ubiquitin-proteasome system in renal disease.International journal of medical sciences · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shuhao GongDepartment of Emergency, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Huawei XiongDepartment of Emergency, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Yingchao LeiDepartment of Emergency, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Shipeng HuangDepartment of Emergency, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Yingdong OuyangDepartment of Emergency, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Chunshui CaoDepartment of Emergency, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.
Ying WangDepartment of Nephrology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a pattern recognition receptor, Toll-like receptor 4 (TLR4) is crucial for the development and progression of acute kidney injury (AKI). This study aims to explore whether the deubiquitinase Usp9x influences the TLR4/NF-B pathway to cause sepsis-induced acute kidney injury (S-AKI). The model of AKI was established in Sprague-Dawley rats using the cecal ligation and puncture (CLP) method, while renal tubular epithelial cell NRK-52E was stimulated with lipopolysaccharide (LPS)

Indexed as

Acute Kidney InjuryApoptosisEpithelial CellsSepsisSignal TransductionUbiquitin ThiolesteraseAnimalsCell LineDisease Models, AnimalInflammationKidney TubulesLipopolysaccharidesMaleNF-kappa BRatsRats, Sprague-DawleyLipopolysaccharidesNF-kappa BTlr4 protein, ratToll-Like Receptor 4Ubiquitin ThiolesteraseapoptosisinflammationSepsis-induced acute kidney injuryTLR4/NF-κBubiquitination modificationUsp9x

Identifiers

PMID38874156
PMCPMC11182076

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.